XML 48 R29.htm IDEA: XBRL DOCUMENT v3.6.0.2
Quarterly Financial Data (Unaudited)
12 Months Ended
Dec. 31, 2016
Quarterly Financial Data (Unaudited)  
Quarterly Financial Data (Unaudited)

Note 22—Quarterly Financial Data (Unaudited)

        A summary of operating results for the quarterly periods in the years ended December 31, 2016 and 2015, is set forth below (in millions, except per share data):

                                                                                                                                                                                    

 

 

Quarter Ended

 

 

 

March 31

 

June 30 (1) (2)

 

September 30 (2)

 

December 31 (1) (2) (3)

 

Year ended December 31, 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$

375.4 

 

$

371.7 

 

$

393.9 

 

$

470.3 

 

Gross profit

 

 

166.8 

 

 

170.1 

 

 

185.2 

 

 

220.4 

 

Operating income

 

 

34.0 

 

 

20.4 

 

 

45.9 

 

 

76.9 

 

Net income attributable to Bruker Corporation

 

 

23.6 

 

 

14.5 

 

 

46.5 

 

 

69.0 

 

Net income per common share attributable to Bruker Corporation shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.14 

 

$

0.09 

 

$

0.29 

 

$

0.43 

 

Diluted

 

$

0.14 

 

$

0.09 

 

$

0.29 

 

$

0.43 

 

Year ended December 31, 2015

 

 


 

 

 


 

 

 


 

 

 


 

 

Net revenue

 

$

353.5 

 

$

396.0 

 

$

396.1 

 

$

478.2 

 

Gross profit

 

 

160.2 

 

 

169.4 

 

 

167.5 

 

 

211.5 

 

Operating income

 

 

15.2 

 

 

31.6 

 

 

28.2 

 

 

70.7 

 

Net income attributable to Bruker Corporation

 

 

6.5 

 

 

21.9 

 

 

11.8 

 

 

61.4 

 

Net income per common share attributable to Bruker Corporation shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.04 

 

$

0.13 

 

$

0.07 

 

$

0.37 

 

Diluted

 

$

0.04 

 

$

0.13 

 

$

0.07 

 

$

0.36 

 


 

 

 

(1)          

The second and fourth quarter of 2016 includes impairment of assets of $0.7 million and $0.1 million, respectively, comprised of other long-lived assets.

(2)          

The second, third and fourth quarter of 2015 includes impairment of assets of $1.8 million, $2.5 million and $0.3 million, respectively, comprised of goodwill, definite-lived intangible assets and other long-lived assets.

(3)          

The fourth quarter of 2016 includes bargain purchase gain of $9.2 million related to the Oxford Instruments Superconducting Wire LLC., acquisition